InvestorsHub Logo
Followers 15
Posts 1122
Boards Moderated 0
Alias Born 07/28/2014

Re: None

Tuesday, 07/10/2018 1:41:07 PM

Tuesday, July 10, 2018 1:41:07 PM

Post# of 536
On February 14th, 2018, the Company conducted a Type B pre-NDA meeting with the FDA to discuss the submission of a 505(b)(2) application for FMX101.

* The expected NDA filing for FMX101 is planned for the end of 2018.